Jennifer Carver - 10 Jan 2022 Form 3 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Director
Signature
/s/ J.P. Galda, as attorney-in-fact for Jennifer Carver
Issuer symbol
REVB
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
3
Filing time
20 Jan 2022, 17:00:00 UTC
Next filing
18 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding REVB Common Stock 68,130 10 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding REVB Restricted Stock Unit 10 Jan 2022 Common Stock 21,422 Direct F1, F2, F3
holding REVB Restricted Stock Unit 10 Jan 2022 Common Stock 21,422 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These RSUs vest quarterly over a four-year period, with the first quarterly vesting scheduled to occur on January 31, 2021.
F2 RSUs do not expire; they either vest or are canceled prior to vesting date.
F3 Each RSU converts into common stock on a one-for-one basis.
F4 These RSUs vest quarterly over a one-year period, with the first quarterly vesting scheduled to occur on May 23, 2021.

Remarks:

Exhibit 24 - Power of Attorney.